Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
3.180
+0.050 (1.60%)
Nov 21, 2024, 4:00 PM EST - Market closed
Zentalis Pharmaceuticals Analyst Ratings
Total Analysts
8
Consensus Rating
Buy
Price Target
$10.50
Upside
+230.19%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Maintains $12 → $8 | Strong Buy | Maintains | $12 → $8 | +151.57% | Nov 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +528.93% | Nov 15, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $20 | Buy | Reiterates | $20 | +528.93% | Sep 16, 2024 |
| Wedbush | Wedbush | Sell → Hold Upgrades $4 | Sell → Hold | Upgrades | $4 | +25.79% | Aug 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +528.93% | Aug 12, 2024 |
| UBS | UBS | Strong Buy → Hold Downgrades $28 → $5 | Strong Buy → Hold | Downgrades | $28 → $5 | +57.23% | Jun 20, 2024 |
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $29 → $9 | Buy → Hold | Downgrades | $29 → $9 | +183.02% | Jun 18, 2024 |
| Stifel | Stifel | Strong Buy Maintains $32 → $10 | Strong Buy | Maintains | $32 → $10 | +214.47% | Jun 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $40 → $20 | Strong Buy | Maintains | $40 → $20 | +528.93% | Jun 18, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $50 → $25 | Buy | Maintains | $50 → $25 | +686.16% | Jun 18, 2024 |
| Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades $38 → $8 | Buy → Hold | Downgrades | $38 → $8 | +151.57% | Jun 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $46 → $40 | Strong Buy | Maintains | $46 → $40 | +1,157.86% | May 8, 2024 |
| Stifel | Stifel | Strong Buy Maintains $36 → $32 | Strong Buy | Maintains | $36 → $32 | +906.29% | May 8, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $46 | Strong Buy | Reiterates | $46 | +1,346.54% | Feb 28, 2024 |
| Wedbush | Wedbush | Hold Maintains $12 → $15 | Hold | Maintains | $12 → $15 | +371.70% | Feb 28, 2024 |
| Wedbush | Wedbush | Buy → Hold Downgrades $38 → $12 | Buy → Hold | Downgrades | $38 → $12 | +277.36% | Nov 8, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.